EUVIMEDEUVIMED entdecken
Crossref

Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy

Xinlong Wang, Yang Cai, Zhaofei Yang, Hui Li, Jinyu Deng, Jiani Zheng, Yue Yuan

Chinese Chemical Letters · 2026-05 · 112931

DOI: 10.1016/j.cclet.2026.112931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Xinlong Wang und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Shenyang Key Laboratory of Functional Drug Carrier Materials.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Shenyang Key Laboratory of Functional Drug Carrier Materials

Zitieren

APA

Wang, X., Cai, Y., Yang, Z., Li, H., Deng, J., Zheng, J., & Yuan, Y. (2026). Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy. Chinese Chemical Letters, 112931. https://doi.org/10.1016/j.cclet.2026.112931

Vancouver

Wang X, Cai Y, Yang Z, Li H, Deng J, Zheng J, et al. Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy. Chinese Chemical Letters. 2026:112931. doi:10.1016/j.cclet.2026.112931

BibTeX
@article{Wang2026,
  author = {Wang, Xinlong and Cai, Yang and Yang, Zhaofei and Li, Hui and Deng, Jinyu and Zheng, Jiani and Yuan, Yue},
  title = {Self-enhancing immunomodulatory nanocomposite hydrogel platform integrates potent ICD induction and immunosuppression reversal for triple-negative breast cancer therapy},
  journal = {Chinese Chemical Letters},
  year = {2026},
  pages = {112931},
  doi = {10.1016/j.cclet.2026.112931}
}
Kostenlos starten →